®2024 CRYOPORT, INC. Condensed Consolidated Statements of Operations (unaudited) | 16 March 31, $ (18,895) $ 46 | 17 Cryoport Enabling the Future of Medicine Increased by 21 trials (net) over Q1 2023 | --- | --- | --- | --- | --- | --- | --- | --- | |---------|-----------|-----------|-----------|-----------|-----------|-----------|-----------| | 350 | 609 | 652 | 675 | 600 | 609 | 652 | 675 | | 300 | | | | 500 | | | | | 250 | | | | 400 | | | | | 200 | | | | 300 | | | | | 150 | | | | 200 | | | | | 100 | | | ...

Exhibit 99.1 Cryoport Reports First Quarter 2024 Financial Results NASHVILLE, Tennessee, May 7, 2024, - Cryoport, Inc. (NASDAQ: CYRX) (Cryoport), a global leader in supply chain solutions for the life sciences, today announced financial results for the three months ended March 31 (Q1), 2024. Jerrell Shelton, CEO of Cryoport, commented, "For the first quarter, we continued to experience a difficult environment globally. Our quarterly results were disappointing, particularly for our Life Sciences Products. Ho ...

NASHVILLE, Tenn., April 30, 2024 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX), a global leader in supply chain solutions for cell & gene therapies, today announced that the Company will report financial results for the first quarter ended March 31, 2024 on Tuesday, May 7, 2024 after U.S. markets close. In addition to the earnings release, a document titled "Cryoport First Quarter 2024 in Review", providing a review of Cryoport's financial and operational performance and a general business update, will be i ...

Cryoport, Inc. (NASDAQ:CYRX) Q4 2023 Earnings Call Transcript March 12, 2024 5:00 PM ET Company Participants Todd Fromer - IR, KCSA Strategic Communications Jerrell Shelton - CEO Mark Sawicki - Chief Scientific Officer Robert Stefanovich - CFO Thomas Heinzen - VP of Corporate Development and IR Conference Call Participants Puneet Souda - Leerink Partners David Saxon - Needham Tejas Savant - Morgan Stanley John Sourbeer - UBS David Larsen - BTIG Yuan Zhi - B. Riley Securities Paul Knight - KeyBanc Operator G ...

CryoPort, Inc. (CYRX) came out with a quarterly loss of $0.51 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to loss of $0.24 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -59.38%. A quarter ago, it was expected that this company would post a loss of $0.31 per share when it actually produced a loss of $0.31, delivering no surprise.Over the last four quarters, the company has surpassed consens ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Nevada 88-0313393 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 112 Westwood Place, Suite 350 Brentwood, TN 37027 (Address of principal executive offices, including zip code) FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 □ TRANSITION REPORT PURSUANT TO SECTION 1 ...

Exhibit 99.1 Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results "Product revenues were lower than historical levels; however, MVE Biological Solutions' revenue began to stabilize in the latter part of the year. Moreover, MVE continues to be a strong business unit, which has generated considerable free cash flow and maintained margins on its product revenue. "Throughout 2023, we made targeted investments in our business and formed strategic relationships to further position ourselves for co ...

Wall Street expects a year-over-year decline in earnings on lower revenues when CryoPort, Inc. (CYRX) reports results for the quarter ended December 2023. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the sto ...

After reaching an important support level, CryoPort, Inc. (CYRX) could be a good stock pick from a technical perspective. CYRX recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.A golden cross is a technical chart pattern that can signify a potential bullish breakout. It's formed from a crossover involving a security's short-term moving average breaking above a longer-term moving average, with the most common moving av ...

Cryoport, Inc. (NASDAQ:CYRX) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ET Company Participants Todd Fromer - Investor Relations Jerrell Shelton - Chief Executive Officer Robert Stefanovich - Chief Financial Officer Mark Sawicki - Chief Scientific Officer Thomas Heinzen - Vice President, Corporate Development and Investor Relations Conference Call Participants Paul Knight - KeyBanc David Saxon - Needham John Sourbeer - UBS Jacob Johnson - Stephens Yuan Zhi - B. Riley David Larsen - BTIG Brand ...